Some states now allow dispensing of oral anticancer medications via practice-based pharmacies. In this segment, Michael Kolodziej, MD, and Ted Okon, MBA, consider the impact of establishing a dispensing pharmacy within a practice.
Dr Kolodziej remarks that although these pharmacies permit patients to receive their medications at their doctor’s office, barriers and concerns including prior authorizations, co-payment costs, and patient adherence remain. Additionally, small practices are not able to negotiate with payers for volume discounts. Comparative effectiveness research could play an important role in addressing some of these issues, suggests Dr Kolodziej.
Many practices have reached out to the Community Oncology Alliance (COA) looking for support and information about operating pharmacies within their practices, notes Mr Okon. To assist practices, the COA recently established the Community Oncology Pharmacy Association to help establish quality standards, among other goals.
Gefurulimab for gMG Meets Key End Points in PREVAIL Trial
July 28th 2025The primary endpoint in PREVAIL is Myasthenia Gravis-Activities of Daily Living total score improvement from baseline, and the secondary endpoints are Quantitative Myasthenia Gravis total score and Myasthenia Gravis Composite total score.
Read More